Stocks Trending Alert:Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Mechel ...

20-02-2014 Comments (0)

Merrimack PharmaceuticalsPharmaceutical

Merrimack Pharmaceuticals, Inc. (MACK) declared the enrollment of its first patient in a Phase 1 dose-escalating clinical study of MM-398 in conjunction with cyclophosphamide for the treatment of ...

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top